Pharmacokinetics/Pharmacodynamics of Dabrafenib and Trametinib for Redifferentiation and Treatment of Radioactive Iodine-Resistant Mutated Advanced Differentiated Thyroid Cancer

Author:

Balakirouchenane David12ORCID,Seban Romain3,Groussin Lionel4,Puszkiel Alicja1,Cottereau Anne Ségolène5,Clerc Jerome5ORCID,Vidal Michel12,Goldwasser Francois3,Arrondeau Jennifer3,Blanchet Benoît12,Huillard Olivier3ORCID

Affiliation:

1. Department of Pharmacokinetics and Pharmacochemistry, Cochin University Hospital, CARPEM, Paris, France.

2. UMR8038 CNRS, U1268 INSERM, Faculté de Pharmacie, Université Paris Cité, PRES Sorbonne Paris Cité, CARPEM, Paris, France.

3. Department of Medical Oncology, Hôpital Cochin, CARPEM, Assistance Publique-Hopitaux de Paris, Paris, France.

4. Department of Endocrinology, Hopital Cochin, Assistance Publique-Hopitaux de Paris, Université Paris Cité, Paris, France.

5. Department of Nuclear Medicine, Hopital Cochin, DMU Imagina, Assistance Publique-Hopitaux de Paris, Université Paris Cité, Paris, France.

Publisher

Mary Ann Liebert Inc

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3